KRISTIN DUHON: Open Payments
NPI 1346618949 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 12 payments from 7 companies in 2025. Trend: 2023 $406 · 2024 $205 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $81 |
| Janssen Biotech, Inc. | 2 | $39 |
| Ipsen Biopharmaceuticals, Inc | 2 | $37 |
| GENZYME CORPORATION | 1 | $21 |
| Madrigal Pharmaceuticals | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Braintree Laboratories, Inc. | 1 | $15 |
Products named: TREMFYA, SKYRIZI, IQIRVO, CREON, DUPIXENT, RINVOQ, REZDIFFRA, TRULANCE.
Industry payments across LA — which companies pay providers there.
